Safety and immunogenicity of the oral,inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind,randomised, placebo-controlled phase 1/2 trial |
| |
| Affiliation: | 1. International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh;2. Gothenburg University Vaccine Research Institute, Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden;3. Scandinavian Biopharma, Solna, Sweden;4. PATH, Washington DC, USA;5. Wake Forest School of Medicine, Section on Infectious Diseases, Department of Internal Medicine, Winston Salem, NC, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
